Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study

Detalhes bibliográficos
Autor(a) principal: Yılmaz Çakirgöz,Mensure
Data de Publicação: 2016
Outros Autores: Demirel,İsmail, Duran,Esra, Özer,Ayşe Belin, Hancı,Volkan, Türkmen,Ülkü Aygen, Aydın,Ahmet, Ersoy,Ayşın, Büyükyıldırım,Aslıhan
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Anestesiologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942016000400356
Resumo: Abstract Aim: To evaluate the effects of three different doses of gabapentin pretreatment on the incidence and severity of myoclonic movements linked to etomidate injection. Method: One hundered patients, between 18 and 60 years of age and risk category American Society of Anesthesiologists I-II, with planned elective surgery under general anesthetic were included in the study. The patients were randomly divided into four groups and 2 h before the operation were given oral capsules of placebo (Group P, n = 25), 400 mg gabapentin (Group G400, n = 25), 800 mg gabapentin (Group G800, n = 25) or 1200 mg gabapentin (Group G1200, n = 25). Side effects before the operation were recorded. After preoxygenation for anesthesia induction 0.3 mg kg−1 etomidate was administered for 10 s. A single anesthetist with no knowledge of the study medication evaluated sedation and myoclonic movements on a scale between 0 and 3. Two minutes after induction, 2 µg kg−1 fentanyl and 0.8 mg kg−1 rocuronium were administered for tracheal intubation. Results: Demographic data were similar. Incidence and severity of myoclonus in Group G1200 and Group G800 were significantly lower than in Group P; sedation incidence and level were appreciably higher compared to Group P and Group G400. While there was no difference in the incidence of myoclonus between Group P and Group G400, the severity of myoclonus in Group G400 was lower than in the placebo group. In the two-hour period before induction other than sedation none of the side effects related to gabapentin were observed in any patient. Conclusion: Pretreatment with 800 mg and 1200 mg gabapentin 2 h before the operation increased the level of sedation and reduced the incidence and severity of myoclonic movements due to etomidate.
id SBA-1_a58de020e180a3df6c8ae0ee2ac8c7e6
oai_identifier_str oai:scielo:S0034-70942016000400356
network_acronym_str SBA-1
network_name_str Revista Brasileira de Anestesiologia (Online)
repository_id_str
spelling Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled studyEtomidateInjection painMyoclonusGabapentinAbstract Aim: To evaluate the effects of three different doses of gabapentin pretreatment on the incidence and severity of myoclonic movements linked to etomidate injection. Method: One hundered patients, between 18 and 60 years of age and risk category American Society of Anesthesiologists I-II, with planned elective surgery under general anesthetic were included in the study. The patients were randomly divided into four groups and 2 h before the operation were given oral capsules of placebo (Group P, n = 25), 400 mg gabapentin (Group G400, n = 25), 800 mg gabapentin (Group G800, n = 25) or 1200 mg gabapentin (Group G1200, n = 25). Side effects before the operation were recorded. After preoxygenation for anesthesia induction 0.3 mg kg−1 etomidate was administered for 10 s. A single anesthetist with no knowledge of the study medication evaluated sedation and myoclonic movements on a scale between 0 and 3. Two minutes after induction, 2 µg kg−1 fentanyl and 0.8 mg kg−1 rocuronium were administered for tracheal intubation. Results: Demographic data were similar. Incidence and severity of myoclonus in Group G1200 and Group G800 were significantly lower than in Group P; sedation incidence and level were appreciably higher compared to Group P and Group G400. While there was no difference in the incidence of myoclonus between Group P and Group G400, the severity of myoclonus in Group G400 was lower than in the placebo group. In the two-hour period before induction other than sedation none of the side effects related to gabapentin were observed in any patient. Conclusion: Pretreatment with 800 mg and 1200 mg gabapentin 2 h before the operation increased the level of sedation and reduced the incidence and severity of myoclonic movements due to etomidate.Sociedade Brasileira de Anestesiologia2016-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942016000400356Revista Brasileira de Anestesiologia v.66 n.4 2016reponame:Revista Brasileira de Anestesiologia (Online)instname:Sociedade Brasileira de Anestesiologia (SBA)instacron:SBA10.1016/j.bjane.2014.11.014info:eu-repo/semantics/openAccessYılmaz Çakirgöz,MensureDemirel,İsmailDuran,EsraÖzer,Ayşe BelinHancı,VolkanTürkmen,Ülkü AygenAydın,AhmetErsoy,AyşınBüyükyıldırım,Aslıhaneng2016-07-21T00:00:00Zoai:scielo:S0034-70942016000400356Revistahttps://www.sbahq.org/revista/https://old.scielo.br/oai/scielo-oai.php||sba2000@openlink.com.br1806-907X0034-7094opendoar:2016-07-21T00:00Revista Brasileira de Anestesiologia (Online) - Sociedade Brasileira de Anestesiologia (SBA)false
dc.title.none.fl_str_mv Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study
title Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study
spellingShingle Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study
Yılmaz Çakirgöz,Mensure
Etomidate
Injection pain
Myoclonus
Gabapentin
title_short Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study
title_full Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study
title_fullStr Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study
title_full_unstemmed Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study
title_sort Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study
author Yılmaz Çakirgöz,Mensure
author_facet Yılmaz Çakirgöz,Mensure
Demirel,İsmail
Duran,Esra
Özer,Ayşe Belin
Hancı,Volkan
Türkmen,Ülkü Aygen
Aydın,Ahmet
Ersoy,Ayşın
Büyükyıldırım,Aslıhan
author_role author
author2 Demirel,İsmail
Duran,Esra
Özer,Ayşe Belin
Hancı,Volkan
Türkmen,Ülkü Aygen
Aydın,Ahmet
Ersoy,Ayşın
Büyükyıldırım,Aslıhan
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Yılmaz Çakirgöz,Mensure
Demirel,İsmail
Duran,Esra
Özer,Ayşe Belin
Hancı,Volkan
Türkmen,Ülkü Aygen
Aydın,Ahmet
Ersoy,Ayşın
Büyükyıldırım,Aslıhan
dc.subject.por.fl_str_mv Etomidate
Injection pain
Myoclonus
Gabapentin
topic Etomidate
Injection pain
Myoclonus
Gabapentin
description Abstract Aim: To evaluate the effects of three different doses of gabapentin pretreatment on the incidence and severity of myoclonic movements linked to etomidate injection. Method: One hundered patients, between 18 and 60 years of age and risk category American Society of Anesthesiologists I-II, with planned elective surgery under general anesthetic were included in the study. The patients were randomly divided into four groups and 2 h before the operation were given oral capsules of placebo (Group P, n = 25), 400 mg gabapentin (Group G400, n = 25), 800 mg gabapentin (Group G800, n = 25) or 1200 mg gabapentin (Group G1200, n = 25). Side effects before the operation were recorded. After preoxygenation for anesthesia induction 0.3 mg kg−1 etomidate was administered for 10 s. A single anesthetist with no knowledge of the study medication evaluated sedation and myoclonic movements on a scale between 0 and 3. Two minutes after induction, 2 µg kg−1 fentanyl and 0.8 mg kg−1 rocuronium were administered for tracheal intubation. Results: Demographic data were similar. Incidence and severity of myoclonus in Group G1200 and Group G800 were significantly lower than in Group P; sedation incidence and level were appreciably higher compared to Group P and Group G400. While there was no difference in the incidence of myoclonus between Group P and Group G400, the severity of myoclonus in Group G400 was lower than in the placebo group. In the two-hour period before induction other than sedation none of the side effects related to gabapentin were observed in any patient. Conclusion: Pretreatment with 800 mg and 1200 mg gabapentin 2 h before the operation increased the level of sedation and reduced the incidence and severity of myoclonic movements due to etomidate.
publishDate 2016
dc.date.none.fl_str_mv 2016-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942016000400356
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942016000400356
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjane.2014.11.014
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Anestesiologia
publisher.none.fl_str_mv Sociedade Brasileira de Anestesiologia
dc.source.none.fl_str_mv Revista Brasileira de Anestesiologia v.66 n.4 2016
reponame:Revista Brasileira de Anestesiologia (Online)
instname:Sociedade Brasileira de Anestesiologia (SBA)
instacron:SBA
instname_str Sociedade Brasileira de Anestesiologia (SBA)
instacron_str SBA
institution SBA
reponame_str Revista Brasileira de Anestesiologia (Online)
collection Revista Brasileira de Anestesiologia (Online)
repository.name.fl_str_mv Revista Brasileira de Anestesiologia (Online) - Sociedade Brasileira de Anestesiologia (SBA)
repository.mail.fl_str_mv ||sba2000@openlink.com.br
_version_ 1752126628961452032